UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 86

Sortiert nach

Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status

Scientific reports, 2014-02, Vol.4 (1), p.4026-4026, Article 4026

2014

Volltextzugriff (PDF)

Treatment of atypical endometrial hyperplasia with an insulin-sensitizing agent

Gynecological endocrinology, 2003-10, Vol.17 (5), p.405-407

2003

Volltextzugriff (PDF)

Dermal and conjunctival melanocytic proliferations in diffuse uveal melanocytic proliferation

Eye (London), 2013-09, Vol.27 (9), p.1058-1062

2013

Volltextzugriff (PDF)

Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer

Cancer research (Chicago, Ill.), 1999-10, Vol.59 (20), p.5370-5375

1999

Volltextzugriff (PDF)

Biological Characterization of Human Epithelial Ovarian Carcinoma Cells in Primary Culture: The Insulin-like Growth Factor System

Experimental cell research, 1998-02, Vol.238 (2), p.439-449

1998

Volltextzugriff (PDF)

Single-Cell Nonphotochemical Hole Burning of Ovarian Surface Epithelial Carcinoma and Normal Cells

Proceedings of the National Academy of Sciences - PNAS, 2003-02, Vol.100 (4), p.1685-1689

2003

Volltextzugriff (PDF)

Nonphotochemical hole burning spectroscopy of a mitochondrial selective rhodamine dye molecule in normal and cancerous ovarian surface epithelial cells

Journal of Luminescence, 2002-07, Vol.98 (1), p.115-121

2002

Volltextzugriff (PDF)

Mapping of the C3b-binding site of CR1 and construction of a (CR1)2-F(ab')2 chimeric complement inhibitor

The Journal of experimental medicine, 1991-12, Vol.174 (6), p.1451-1460

1991

Volltextzugriff (PDF)

Carcinoma and SV40-Transfected Normal Ovarian Surface Epithelial Cell Comparison by Nonphotochemical Hole Burning

Biophysical journal, 2003-02, Vol.84 (2), p.1299-1307

2003

Volltextzugriff (PDF)

Interaction of iC3b with recombinant isotypic and chimeric forms of CR2

The Journal of immunology (1950), 1991-07, Vol.147 (2), p.590

1991

Volltextzugriff (PDF)

Determination of the structural basis for selective binding of Epstein-Barr virus to human complement receptor type 2

The Journal of experimental medicine, 1991-12, Vol.174 (6), p.1299-1311

1991

Volltextzugriff (PDF)

The immune system in the pathogenesis of ovarian cancer

Critical reviews in immunology, 2013, Vol.33 (2), p.137

2013

Volltextzugriff (PDF)

Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study

British journal of cancer, 2014-12, Vol.111 (12), p.2297-2307

2014

Volltextzugriff (PDF)

Binding of C3b and C4b by the CR1-like site in murine CR1

The Journal of immunology (1950), 1994-03, Vol.152 (6), p.2899

1994

Volltextzugriff (PDF)

Interleukin-1 signal transduction

Life Sciences, 1996, Vol.59 (2), p.61-83

1996

Volltextzugriff (PDF)

Delta-opioid receptors expressed by Jurkat T cells enhance IL-2 secretion by increasing AP-1 complexes and activity of the NF-AT/AP-1-binding promoter element

The Journal of immunology (1950), 1997-12, Vol.159 (11), p.5431

1997

Volltextzugriff (PDF)

Mechanisms of Lysolipid Phosphate Effects on Cellular Survival and Proliferation

Annals of the New York Academy of Sciences, 2000-04, Vol.905 (1), p.177-187

2000

Volltextzugriff (PDF)

In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417

Cancer research (Chicago, Ill.), 2006-01, Vol.66 (1), p.362-371

2006

Volltextzugriff (PDF)

Abstract 4246: Comparison of pathology versus IHC-based ovarian carcinoma histology assignment using gene expression, DNA methylation, and clinical outcome data

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4246-4246

2015

Volltextzugriff (PDF)

Intraperitoneal therapy of ovarian cancer using an engineered measles virus

Cancer research (Chicago, Ill.), 2002-08, Vol.62 (16), p.4656-4662

2002

Volltextzugriff (PDF)

Ovarian Avatar Models Predictive of Platinum Response in Ovarian Cancer Patients

Annals of oncology, 2013-03, Vol.24, p.i7-i7

2013

Volltextzugriff (PDF)

Gene Expression Profiles Predict Early Relapse in Ovarian Cancer after Platinum-Paclitaxel Chemotherapy

Clinical cancer research, 2005-03, Vol.11 (6), p.2149-2155

2005

Volltextzugriff (PDF)

MORAb-003, a fully humanized monoclonal antibody against the folate receptor alpha, for the potential treatment of epithelial ovarian cancer

Current opinion in investigational drugs (London, England : 2000), 2007-12, Vol.8 (12), p.1067

Kalli, Kimberly R

2007

Volltextzugriff (PDF)

Functional Insulin Receptors on Human Epithelial Ovarian Carcinoma Cells: Implications for IGF-II Mitogenic Signaling

Endocrinology (Philadelphia), 2002-09, Vol.143 (9), p.3259-3267

2002

Volltextzugriff (PDF)

Abstract P2-11-02: Robust generation of T cell immunity to HER2 in HER2+ breast cancer patients with a degenerate subdominant HLA-DR epitope vaccine

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P2-P2-11-02

2016

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(77)

Publikationsform

Artikel
(85)
Tagungsberichte
(1)

Sprache

Englisch
(86)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status

Treatment of atypical endometrial hyperplasia with an insulin-sensitizing agent

Dermal and conjunctival melanocytic proliferations in diffuse uveal melanocytic proliferation

Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer

Biological Characterization of Human Epithelial Ovarian Carcinoma Cells in Primary Culture: The Insulin-like Growth Factor System

Single-Cell Nonphotochemical Hole Burning of Ovarian Surface Epithelial Carcinoma and Normal Cells

Nonphotochemical hole burning spectroscopy of a mitochondrial selective rhodamine dye molecule in normal and cancerous ovarian surface epithelial cells

Mapping of the C3b-binding site of CR1 and construction of a (CR1)2-F(ab')2 chimeric complement inhibitor

Carcinoma and SV40-Transfected Normal Ovarian Surface Epithelial Cell Comparison by Nonphotochemical Hole Burning

Interaction of iC3b with recombinant isotypic and chimeric forms of CR2

Determination of the structural basis for selective binding of Epstein-Barr virus to human complement receptor type 2

The immune system in the pathogenesis of ovarian cancer

Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study

Binding of C3b and C4b by the CR1-like site in murine CR1

Interleukin-1 signal transduction

Delta-opioid receptors expressed by Jurkat T cells enhance IL-2 secretion by increasing AP-1 complexes and activity of the NF-AT/AP-1-binding promoter element

Mechanisms of Lysolipid Phosphate Effects on Cellular Survival and Proliferation

In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417

Abstract 4246: Comparison of pathology versus IHC-based ovarian carcinoma histology assignment using gene expression, DNA methylation, and clinical outcome data

Intraperitoneal therapy of ovarian cancer using an engineered measles virus

Ovarian Avatar Models Predictive of Platinum Response in Ovarian Cancer Patients

Gene Expression Profiles Predict Early Relapse in Ovarian Cancer after Platinum-Paclitaxel Chemotherapy

MORAb-003, a fully humanized monoclonal antibody against the folate receptor alpha, for the potential treatment of epithelial ovarian cancer

Functional Insulin Receptors on Human Epithelial Ovarian Carcinoma Cells: Implications for IGF-II Mitogenic Signaling

Abstract P2-11-02: Robust generation of T cell immunity to HER2 in HER2+ breast cancer patients with a degenerate subdominant HLA-DR epitope vaccine

Suchergebnisse filtern